- COVID-19
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial - The Lancet
29-4-2020; https://marlin-prod.literatumonline.com/pb-assets/Lancet/pdfs/S0140673620310229.pdf
By: Wang, et al.
Aim: Investigate the effectiveness of 10 days IV remdesivir in patients with severe COVID-19 in a placebo-controlled, double-blind trial